UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
||||
FORM
8-K
|
||||
CURRENT
REPORT
|
||||
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
||||
Date
of Report (date of earliest event reported): February 5,
2008
|
||||
AMS
HEALTH SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
|
||||
OKLAHOMA
(State
or other jurisdiction of incorporation)
|
001−13343
(Commission
File Number)
|
73-1323256
(I.R.S.
Employer Identification No.)
|
||
711
NE 39th Street,
Oklahoma City, OK
(Address
of principal executive offices)
|
73105
(Zip
Code)
|
|||
Registrant’s
telephone number, including area code: (405) 842-0131
|
||||
Not
Applicable
(Former
name or former address, if changed since last report.)
|
||||
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under
any
of the following provisions:
|
||||
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
|||
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|||
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
|||
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13a-4(c))
|
Item
1.03
|
Bankruptcy
or Receivership
|
Item
9.01
|
Financial
Statements and Exhibits.
|
AMS
HEALTH SCIENCES, INC.
|
|
(Registrant)
|
|
Date: February
8, 2008
|
By:/s/
Jerry W.
Grizzle
|
Jerry
W. Grizzle
|
|
President
and Chief Executive Officer
|
Exhibit
Number
|
Exhibit Description
|
|
99.1*
|
Letter
from the United States Bankruptcy Court, Western District of Oklahoma
to
the common stock shareholders of AMS Health Sciences, Inc.
|